Charles Schwab Investment Management »

Bridgebio Oncology Therapeut shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Bridgebio Oncology Therapeut shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Bridgebio Oncology Therapeut

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Oncology Therapeut held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Oncology Therapeut by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.2M 279k 11.58

More positions owned by Charles Schwab Investment Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Schwab Strategic Tr Fundamental Us L (FNDX)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Schwab Strategic Tr Fundamental Intl (FNDF)
Abbvie (ABBV)
JPMorgan Chase & Co. (JPM)
Home Depot (HD)
Schwab Strategic Tr Int-trm U.s Tres (SCHR)

View all positions for Charles Schwab Investment Management

Top funds holding Bridgebio Oncology Therapeut

Cormorant Asset Management
Deerfield Management Company
Omega Fund Management
Wellington Management Company
Alphabet
EcoR1 Capital
Enavate Sciences GP
Citadel Advisors
BlackRock
Novo A/S
Paradigm Biocapital Advisors
Adage Capital Partners GP
Eventide Asset Management
Laurion Capital Management
Octagon Capital Advisors

View all funds holding Bridgebio Oncology Therapeut